$NEO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEOGENOMICS INC. Get notifications about new insider transactions in NEOGENOMICS INC for free.
Page: < prev 1 2 3 4 5 6 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 08 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Buy | M | 7.52 | 7,200 | 54,144 | 13,935 | 6.7 K to 13.9 K (+106.90 %) |
May 06 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 7.52 | 13,333 | 100,264 | 26,667 | |
May 06 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 7.15 | 16,667 | 119,169 | 0 | |
May 06 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 22.74 | 13,333 | 303,192 | 22,862 | 36.2 K to 22.9 K (-36.84 %) |
May 06 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 22.74 | 16,667 | 379,008 | 36,195 | 52.9 K to 36.2 K (-31.53 %) |
May 06 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 7.52 | 13,333 | 100,264 | 52,862 | 39.5 K to 52.9 K (+33.73 %) |
May 06 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 7.15 | 16,667 | 119,169 | 39,529 | 22.9 K to 39.5 K (+72.90 %) |
May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.52 | 66,667 | 501,336 | 66,667 | |
May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.15 | 66,666 | 476,662 | 0 | |
May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 22.14 | 66,667 | 1,476,007 | 162,307 | 229 K to 162.3 K (-29.12 %) |
May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 22.14 | 52,680 | 1,166,335 | 228,974 | 281.7 K to 229 K (-18.70 %) |
May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.52 | 66,667 | 501,336 | 281,654 | 215 K to 281.7 K (+31.01 %) |
May 06 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.15 | 66,666 | 476,662 | 214,987 | 148.3 K to 215 K (+44.95 %) |
May 06 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 4.78 | 200,000 | 956,000 | 0 | |
May 06 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 22.82 | 151,676 | 3,461,246 | 300,831 | 452.5 K to 300.8 K (-33.52 %) |
May 06 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 4.78 | 200,000 | 956,000 | 452,507 | 252.5 K to 452.5 K (+79.21 %) |
Mar 05 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 19.60 | 231,567 | 4,538,713 | 231,567 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 37,883 | 0 | 2,092,435 | 2.1 M to 2.1 M (+1.84 %) |
Mar 05 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 19.60 | 66,897 | 1,311,181 | 66,897 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 10,944 | 0 | 148,321 | 137.4 K to 148.3 K (+7.97 %) |
Mar 05 2019 | NEO | NEOGENOMICS INC | Virag Sharon | Chief Financial Off ... | Option Exercise | A | 19.60 | 66,897 | 1,311,181 | 66,897 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | Virag Sharon | Chief Financial Off ... | Grant | A | 0.00 | 10,944 | 0 | 10,944 | 0 to 10.9 K |
Mar 05 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | A | 19.60 | 51,459 | 1,008,596 | 51,459 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Grant | A | 0.00 | 8,418 | 0 | 252,507 | 244.1 K to 252.5 K (+3.45 %) |
Mar 05 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Option Exercise | A | 19.60 | 41,167 | 806,873 | 41,167 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Grant | A | 0.00 | 6,735 | 0 | 6,735 | 0 to 6.7 K |
Mar 05 2019 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Scientific Of ... | Option Exercise | A | 19.60 | 36,022 | 706,031 | 36,022 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Scientific Of ... | Grant | A | 0.00 | 5,893 | 0 | 5,893 | 0 to 5.9 K |
Mar 05 2019 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Scientific Of ... | Option Exercise | A | 19.60 | 36,022 | 706,031 | 36,022 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Scientific Of ... | Grant | A | 0.00 | 5,893 | 0 | 5,893 | 0 to 5.9 K |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 8.03 | 14,000 | 112,420 | 48,500 | |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 19.60 | 17,496 | 342,922 | 17,496 | |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 7.52 | 20,000 | 150,400 | 40,000 | |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 8.03 | 10,000 | 80,300 | 62,500 | |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 19.09 | 14,000 | 267,260 | 22,862 | 36.9 K to 22.9 K (-37.98 %) |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 8.03 | 14,000 | 112,420 | 36,862 | 22.9 K to 36.9 K (+61.24 %) |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Grant | A | 0.00 | 2,862 | 0 | 22,862 | 20 K to 22.9 K (+14.31 %) |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 19.57 | 30,000 | 587,100 | 20,000 | 50 K to 20 K (-60.00 %) |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 8.03 | 10,000 | 80,300 | 50,000 | 40 K to 50 K (+25.00 %) |
Mar 04 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 7.52 | 20,000 | 150,400 | 40,000 | 20 K to 40 K (+100.00 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 19.24 | 1,000 | 19,240 | 47,657 | 48.7 K to 47.7 K (-2.06 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 18.78 | 32,371 | 607,927 | 150,000 | 182.4 K to 150 K (-17.75 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 19.27 | 1,900 | 36,613 | 182,371 | 184.3 K to 182.4 K (-1.03 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 18.90 | 252,881 | 4,779,451 | 1,900,000 | 2.2 M to 1.9 M (-11.75 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 19.24 | 11,721 | 225,512 | 2,152,881 | 2.2 M to 2.2 M (-0.54 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 3.45 | 30,000 | 103,500 | 0 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 3.45 | 30,000 | 103,500 | 244,089 | 214.1 K to 244.1 K (+14.01 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.52 | 66,666 | 501,328 | 133,334 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.15 | 13,986 | 100,000 | 66,666 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 7.15 | 119,348 | 853,338 | 80,652 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.15 | 13,986 | 100,000 | 137,377 | 123.4 K to 137.4 K (+11.33 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 19.23 | 44,135 | 848,716 | 123,391 | 167.5 K to 123.4 K (-26.35 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 18.88 | 141,879 | 2,678,676 | 167,526 | 309.4 K to 167.5 K (-45.86 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.52 | 66,666 | 501,328 | 309,405 | 242.7 K to 309.4 K (+27.46 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 7.15 | 119,348 | 853,338 | 242,739 | 123.4 K to 242.7 K (+96.72 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Option Exercise | M | 7.52 | 20,037 | 150,678 | 79,963 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Option Exercise | M | 8.03 | 40,166 | 322,533 | 80,334 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Sell | S | 18.90 | 60,203 | 1,137,837 | 0 | 60.2 K to 0 (-100.00 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Buy | M | 7.52 | 20,037 | 150,678 | 60,203 | 40.2 K to 60.2 K (+49.89 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Buy | M | 8.03 | 40,166 | 322,533 | 40,166 | 0 to 40.2 K |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | M | 7.27 | 3,333 | 24,231 | 6,667 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | M | 9.11 | 5,556 | 50,615 | 2,777 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | M | 4.78 | 10,000 | 47,800 | 0 | |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Sell | S | 18.90 | 18,889 | 357,002 | 287,580 | 306.5 K to 287.6 K (-6.16 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 7.27 | 3,333 | 24,231 | 306,469 | 303.1 K to 306.5 K (+1.10 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 9.11 | 5,556 | 50,615 | 303,136 | 297.6 K to 303.1 K (+1.87 %) |
Feb 28 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 4.78 | 10,000 | 47,800 | 297,580 | 287.6 K to 297.6 K (+3.48 %) |
Dec 26 2018 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | P | 11.60 | 26,000 | 301,600 | 103,866 | 77.9 K to 103.9 K (+33.39 %) |
Dec 14 2018 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Scientific Of ... | Option Exercise | A | 13.87 | 25,000 | 346,750 | 25,000 | |
Dec 14 2018 | NEO | NEOGENOMICS INC | GENERAL ELECTRIC CO | Sell | S | 12.00 | 10,835,145 | 130,021,740 | 0 | 10.8 M to 0 (-100.00 %) | |
Nov 21 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Sell | S | 15.97 | 2,000 | 31,940 | 38,234 | 40.2 K to 38.2 K (-4.97 %) |
Nov 21 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Sell | S | 16.00 | 11,000 | 176,000 | 40,234 | 51.2 K to 40.2 K (-21.47 %) |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 7.27 | 3,333 | 24,231 | 6,667 | |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 9.11 | 5,555 | 50,606 | 2,778 | |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 6.66 | 10,000 | 66,600 | 0 | |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Sell | S | 16.16 | 5,000 | 80,800 | 51,234 | 56.2 K to 51.2 K (-8.89 %) |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 7.27 | 3,333 | 24,231 | 56,234 | 52.9 K to 56.2 K (+6.30 %) |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 9.11 | 5,555 | 50,606 | 52,901 | 47.3 K to 52.9 K (+11.73 %) |
Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 6.66 | 10,000 | 66,600 | 47,346 | 37.3 K to 47.3 K (+26.78 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 7.15 | 33,333 | 238,331 | 16,667 | |
Nov 13 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 4.78 | 35,000 | 167,300 | 0 | |
Nov 13 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 16.73 | 28,505 | 476,889 | 20,000 | 48.5 K to 20 K (-58.77 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 17.00 | 39,828 | 677,076 | 48,505 | 88.3 K to 48.5 K (-45.09 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 0.00 | 33,333 | 0 | 88,333 | 55 K to 88.3 K (+60.61 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 4.78 | 35,000 | 167,300 | 55,000 | 20 K to 55 K (+175.00 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | GENERAL ELECTRIC CO | 10% Owner | Sell | S | 16.75 | 4,164,855 | 69,761,321 | 10,835,145 | 15 M to 10.8 M (-27.77 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Sell | S | 17.08 | 20,007 | 341,720 | 77,866 | 97.9 K to 77.9 K (-20.44 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Sell | S | 17.01 | 46,000 | 782,460 | 97,873 | 143.9 K to 97.9 K (-31.97 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 4.79 | 300,000 | 1,437,000 | 0 | |
Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 16.76 | 36,493 | 611,623 | 123,391 | 159.9 K to 123.4 K (-22.82 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 17.05 | 180,000 | 3,069,000 | 159,884 | 339.9 K to 159.9 K (-52.96 %) |
Nov 13 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 4.79 | 300,000 | 1,437,000 | 339,884 | 39.9 K to 339.9 K (+752.18 %) |
Oct 24 2018 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | VP - Pharma Operat ... | Option Exercise | M | 3.45 | 13,334 | 46,002 | 0 | |
Oct 24 2018 | NEO | NEOGENOMICS INC | BRODIE STEVEN G. | VP - Pharma Operat ... | Buy | M | 3.45 | 13,334 | 46,002 | 45,953 | 32.6 K to 46 K (+40.88 %) |
Aug 03 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 46,429 | 0 | 2,054,552 | 2 M to 2.1 M (+2.31 %) |
Aug 01 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 14.00 | 119,948 | 1,679,272 | 2,300,000 | 2.4 M to 2.3 M (-4.96 %) |
Aug 01 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 14.00 | 38,952 | 545,328 | 2,419,948 | 2.5 M to 2.4 M (-1.58 %) |
Aug 01 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 14.01 | 41,100 | 575,811 | 2,458,900 | 2.5 M to 2.5 M (-1.64 %) |
Aug 01 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 14.00 | 3,500 | 49,000 | 48,657 | 52.2 K to 48.7 K (-6.71 %) |
Jun 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 13.12 | 12,941 | 169,786 | 39,884 | 52.8 K to 39.9 K (-24.50 %) |
Jun 26 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 14.04 | 89,688 | 1,259,220 | 2,500,000 | 2.6 M to 2.5 M (-3.46 %) |
Jun 26 2018 | NEO | NEOGENOMICS INC | GENERAL ELECTRIC CO | 10% Owner | Option Exercise | J | 7.50 | 6,864,000 | 51,480,000 | 0 | |
Jun 19 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 13.32 | 158,312 | 2,108,067 | 2,589,688 | 2.7 M to 2.6 M (-5.76 %) |
Jun 19 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 13.25 | 2,000 | 26,500 | 2,748,000 | 2.8 M to 2.7 M (-0.07 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
Jun 05 2018 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Grant | A | 0.00 | 15,564 | 0 | 143,873 | 128.3 K to 143.9 K (+12.13 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
Jun 05 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 15,564 | 0 | 37,346 | 21.8 K to 37.3 K (+71.45 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
Jun 05 2018 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Grant | A | 0.00 | 15,564 | 0 | 32,766 | 17.2 K to 32.8 K (+90.48 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
Jun 05 2018 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 15,564 | 0 | 61,013 | 45.4 K to 61 K (+34.24 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
Jun 05 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 12.12 | 230,533 | 2,794,060 | 2,750,000 | 3 M to 2.8 M (-7.73 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Grant | A | 0.00 | 6,897 | 0 | 241,815 | 234.9 K to 241.8 K (+2.94 %) |
Jun 05 2018 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
Jun 05 2018 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Grant | A | 0.00 | 15,564 | 0 | 287,580 | 272 K to 287.6 K (+5.72 %) |
May 31 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 11.68 | 17,548 | 204,961 | 2,980,533 | 3 M to 3 M (-0.59 %) |
May 31 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 11.72 | 37,619 | 440,895 | 2,998,081 | 3 M to 3 M (-1.24 %) |
May 31 2018 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive Vice Pres ... | Sell | S | 11.67 | 114,300 | 1,333,881 | 3,035,700 | 3.2 M to 3 M (-3.63 %) |
May 31 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 4.78 | 65,000 | 310,700 | 35,000 | |
May 31 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 11.70 | 35,000 | 409,500 | 13,322 | 48.3 K to 13.3 K (-72.43 %) |
May 31 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 11.62 | 30,000 | 348,600 | 48,322 | 78.3 K to 48.3 K (-38.30 %) |
May 31 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 4.78 | 65,000 | 310,700 | 78,322 | 13.3 K to 78.3 K (+487.91 %) |
May 29 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 0.00 | 65,680 | 0 | 131,362 | |
May 29 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 11.57 | 21,904 | 253,429 | 1,876,761 | 1.9 M to 1.9 M (-1.15 %) |
May 29 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 0.00 | 65,680 | 0 | 1,898,665 | 1.8 M to 1.9 M (+3.58 %) |
May 29 2018 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
May 29 2018 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 0.00 | 8,333 | 0 | 197,422 | 189.1 K to 197.4 K (+4.41 %) |
May 29 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 0.00 | 6,666 | 0 | 13,334 | |
May 29 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 0.00 | 6,666 | 0 | 6,666 | 0 to 6.7 K |
May 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 0.00 | 16,666 | 0 | 33,334 | |
May 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 11.57 | 3,725 | 43,098 | 19,491 | 23.2 K to 19.5 K (-16.04 %) |
May 29 2018 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 0.00 | 16,666 | 0 | 23,216 | 6.6 K to 23.2 K (+254.44 %) |
May 17 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 4.78 | 13,000 | 62,140 | 100,000 | |
May 17 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 11.26 | 6,500 | 73,190 | 0 | 6.5 K to 0 (-100.00 %) |
May 17 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 11.21 | 6,500 | 72,865 | 6,500 | 13 K to 6.5 K (-50.00 %) |
May 17 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 4.78 | 13,000 | 62,140 | 13,000 | 0 to 13 K |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 7.52 | 21,666 | 162,928 | 43,334 | |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 7.15 | 26,666 | 190,662 | 13,334 | |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Option Exercise | X | 4.78 | 33,667 | 160,928 | 0 | |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Sell | S | 10.78 | 81,999 | 883,949 | 4,500 | 86.5 K to 4.5 K (-94.80 %) |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 7.52 | 21,666 | 162,928 | 86,499 | 64.8 K to 86.5 K (+33.42 %) |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 7.15 | 26,666 | 190,662 | 64,833 | 38.2 K to 64.8 K (+69.87 %) |
May 10 2018 | NEO | NEOGENOMICS INC | ROSS STEVEN A | CIO | Buy | M | 4.78 | 33,667 | 160,928 | 38,167 | 4.5 K to 38.2 K (+748.16 %) |
Mar 28 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 4.78 | 7,000 | 33,460 | 113,000 | |
Mar 28 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | D | 8.20 | 7,000 | 57,400 | 0 | 7 K to 0 (-100.00 %) |
Mar 28 2018 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 4.78 | 7,000 | 33,460 | 7,000 | 0 to 7 K |
Mar 28 2018 | NEO | NEOGENOMICS INC | Virag Sharon | Chief Financial Off ... | Option Exercise | A | 8.22 | 192,500 | 1,582,350 | 192,500 | |
Feb 28 2018 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Principal Accountin ... | Option Exercise | A | 8.03 | 48,000 | 385,440 | 48,000 |